Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Domicile of entity | — |
Belgium
|
— |
| Legal form of entity | — |
NV
|
— |
| Country of incorporation | — |
Belgium
|
— |
| Address of entity's registered office | — |
Generaal de Wittelaan 11 B, 2800 Mechelen
|
— |
| Principal place of business | — |
Mechelen
|
— |
| Description of nature of entity's operations and principal activities | — |
commercialize an innovative and proprietary molecular diagnostics (‘MDx’) platform that offers accurate, highly-reliable molecular information from virtually any biological sample, enabling fast and effective diagnostics treatment selection and treatment progress monitoring
|
— |
| Name of parent entity | — |
Biocartis Group NV
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
16,106,000
EUR
|
— |
15,712,000
EUR
|